News

華爾街見聞
2022.08.17 23:46
13F 報告顯示：Pure Play Health Care 類基金二季度在醫藥和生物科技板塊買入 MoonLake Immunotherapeutics（HLXA，SPAC 類股）最多，賣出 Mereo Biopharma Group Plc.（MREO）最多；二季度總體持倉市值 626 億美元。
Source: 華爾街見聞 The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.